BPC-157 may be evaluated for localized injury concerns, while TB-500 may be considered for broader tissue support
The first human safety study on health volunteers was conducted in 2002 and a phase 2 double blind, randomized clinical trial (small and not sufficient for US phase 2 purposes) was conducted in 2005 with BPC-157 enemas for ulcerative colitis, with some promising effects (see research name PL 14736 to find the references)
See what changes the dose above for why the same nominal dose lands differently across populations
Reported benefits include improved recovery speeds, decreased inflammation and pain, and enhanced flexibility with reduced risk of future injury when paired with rehab
A Re: News investigation finds peptides are being illegally sold in broad daylight, and customers are turning to AI chatbots to tell them how to inject the substances
Timing is important in reproductive care